Alphatec (ATEC)
(Delayed Data from NSDQ)
$10.87 USD
-0.04 (-0.37%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $10.86 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Alphatec (ATEC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.32 | $26.00 | $16.00 | 95.42% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Alphatec comes to $21.32. The forecasts range from a low of $16.00 to a high of $26.00. The average price target represents an increase of 95.42% from the last closing price of $10.91.
Analyst Price Targets (11)
Broker Rating
Alphatec currently has an average brokerage recommendation (ABR) of 1.08 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.09 a month ago based on 11 recommendations.
Of the 12 recommendations deriving the current ABR, 11 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 91.67% and 8.33% of all recommendations. A month ago, Strong Buy made up 90.91%, while Buy represented 9.09%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ATEC.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 10 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.08 | 1.08 | 1.09 | 1.09 | 1.09 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/11/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/8/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/8/2024 | Roth Capital Partners | Jason Wittes | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
3/20/2024 | Canaccord Genuity | Caitlin Cronin | Not Available | Strong Buy |
3/20/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
3/13/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
3/4/2024 | H.C. Wainwright & Co. | Sean Lee | Strong Buy | Strong Buy |
2/26/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
2/9/2024 | Wells Fargo Securities | Vikramjeet S Chopra | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.08 |
ABR (Last week) | 1.08 |
# of Recs in ABR | 12 |
Average Target Price | $21.32 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 103 of 252 |
Current Quarter EPS Est: | -0.26 |